Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Jones

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of SmoothenedMichael J Munchhof, Qifang Li, Andrei Shavnya, et al.
Clinical Nuclear Medicine|January 24, 2017
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal MassesSara Sheikhbahaei, Christopher S Jones, Kristin K Porter, et al.
Chemical Research in Toxicology|October 16, 2007
A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motifAmit S Kalgutkar, James Driscoll, Sabrina X Zhao, et al.
Protein Expression and Purification|May 12, 2010
Baculovirus production of fully-active phosphoinositide 3-kinase alpha as a p85alpha-p110alpha fusion for X-ray crystallographic analysis with ATP competitive enzyme inhibitorsRobert H Sinnamon, Patrick McDevitt, Beth L Pietrak, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2010
Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptorAmy S Antipas, Laura C Blumberg, William H Brissette, et al.
Assay and Drug Development Technologies|June 19, 2013
Development of a high-throughput screen to detect inhibitors of TRPS1 sumoylationMartin Brandt, Lawrence M Szewczuk, Hong Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motifKevin J Filipski, Angel Guzman-Perez, Jianwei Bian, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1Lawrence A Reiter, Ralph P Robinson, Kim F McClure, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2007
Pyrimidine benzamide-based thrombopoietin receptor agonistsLawrence A Reiter, Chakrapani Subramanyam, Emilio J Mangual, et al.
Journal of Medicinal Chemistry|December 14, 2011
Maximizing lipophilic efficiency: the use of Free-Wilson analysis in the design of inhibitors of acetyl-CoA carboxylaseKevin D Freeman-Cook, Paul Amor, Scott Bader, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of SmoothenedMichael J Munchhof, Qifang Li, Andrei Shavnya, et al.
Clinical Nuclear Medicine|January 24, 2017
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal MassesSara Sheikhbahaei, Christopher S Jones, Kristin K Porter, et al.
Chemical Research in Toxicology|October 16, 2007
A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motifAmit S Kalgutkar, James Driscoll, Sabrina X Zhao, et al.
Protein Expression and Purification|May 12, 2010
Baculovirus production of fully-active phosphoinositide 3-kinase alpha as a p85alpha-p110alpha fusion for X-ray crystallographic analysis with ATP competitive enzyme inhibitorsRobert H Sinnamon, Patrick McDevitt, Beth L Pietrak, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2010
Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptorAmy S Antipas, Laura C Blumberg, William H Brissette, et al.
Assay and Drug Development Technologies|June 19, 2013
Development of a high-throughput screen to detect inhibitors of TRPS1 sumoylationMartin Brandt, Lawrence M Szewczuk, Hong Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motifKevin J Filipski, Angel Guzman-Perez, Jianwei Bian, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1Lawrence A Reiter, Ralph P Robinson, Kim F McClure, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2007
Pyrimidine benzamide-based thrombopoietin receptor agonistsLawrence A Reiter, Chakrapani Subramanyam, Emilio J Mangual, et al.
Journal of Medicinal Chemistry|December 14, 2011
Maximizing lipophilic efficiency: the use of Free-Wilson analysis in the design of inhibitors of acetyl-CoA carboxylaseKevin D Freeman-Cook, Paul Amor, Scott Bader, et al.
Pageof 5